Literature DB >> 27380738

Progesterone Receptor Signaling Mechanisms.

Sandra L Grimm1, Sean M Hartig1, Dean P Edwards2.   

Abstract

Progesterone receptor (PR) is a master regulator in female reproductive tissues that controls developmental processes and proliferation and differentiation during the reproductive cycle and pregnancy. PR also plays a role in progression of endocrine-dependent breast cancer. As a member of the nuclear receptor family of ligand-dependent transcription factors, the main action of PR is to regulate networks of target gene expression in response to binding its cognate steroid hormone, progesterone. This paper summarizes recent advances in understanding the structure-function properties of the receptor protein and the tissue/cell-type-specific PR signaling pathways that contribute to the biological actions of progesterone in the normal breast and in breast cancer.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  RANKL; breast cancer; mammary gland; stem cells; structural dynamics

Mesh:

Substances:

Year:  2016        PMID: 27380738     DOI: 10.1016/j.jmb.2016.06.020

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  46 in total

Review 1.  Neuroimmunology and neuroepigenetics in the establishment of sex differences in the brain.

Authors:  Margaret M McCarthy; Bridget M Nugent; Kathryn M Lenz
Journal:  Nat Rev Neurosci       Date:  2017-06-22       Impact factor: 34.870

Review 2.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

3.  Interaction of the phosphorylated DNA-binding domain in nuclear receptor CAR with its ligand-binding domain regulates CAR activation.

Authors:  Ryota Shizu; Jungki Min; Mack Sobhany; Lars C Pedersen; Shingo Mutoh; Masahiko Negishi
Journal:  J Biol Chem       Date:  2017-11-13       Impact factor: 5.157

Review 4.  Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

Authors:  Viroj Boonyaratanakornkit; Nalo Hamilton; Diana C Márquez-Garbán; Prangwan Pateetin; Eileen M McGowan; Richard J Pietras
Journal:  Mol Cell Endocrinol       Date:  2017-11-14       Impact factor: 4.102

Review 5.  Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.

Authors:  Kanchan Sonkar; Vinay Ayyappan; Caitlin M Tressler; Oluwatobi Adelaja; Ruoqing Cai; Menglin Cheng; Kristine Glunde
Journal:  NMR Biomed       Date:  2019-06-11       Impact factor: 4.044

6.  In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment.

Authors:  Vahid Zarezade; Marzie Abolghasemi; Fakher Rahim; Ali Veisi; Mohammad Behbahani
Journal:  J Mol Model       Date:  2018-11-10       Impact factor: 1.810

7.  Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.

Authors:  Tengteng Wang; Lauren E McCullough; Alexandra J White; Patrick T Bradshaw; Xinran Xu; Yoon Hee Cho; Mary Beth Terry; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella; Jia Chen; Marilie D Gammon
Journal:  Cancer       Date:  2019-08-12       Impact factor: 6.860

Review 8.  Progesterone Receptor Signaling in Uterine Myometrial Physiology and Preterm Birth.

Authors:  San-Pin Wu; Francesco J DeMayo
Journal:  Curr Top Dev Biol       Date:  2017-04-26       Impact factor: 4.897

Review 9.  90 YEARS OF PROGESTERONE: New insights into progesterone receptor signaling in the endometrium required for embryo implantation.

Authors:  Francesco J DeMayo; John P Lydon
Journal:  J Mol Endocrinol       Date:  2020-07       Impact factor: 5.098

10.  Circadian rhythms in the mouse reproductive axis during the estrous cycle and pregnancy.

Authors:  Alexandra M Yaw; Thu V Duong; Duong Nguyen; Hanne M Hoffmann
Journal:  J Neurosci Res       Date:  2020-03-03       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.